Sharma East India closes trading window ahead of Q2FY27 results

scanx
Reviewed by
Suketu GScanX News Team
Key Highlights
  • Trading window closes October 1, 2026, for all Designated Persons
  • Closure covers Q2FY27 standalone un-audited financial results
  • Window reopens 48 hours after results become publicly available
  • Notice filed with BSE Limited pursuant to April 2, 2019 circular
powered bylight_fuzz_icon
52235494

*this image is generated using AI for illustrative purposes only.

Sharma East India Hospitals and Medical Research Ltd has announced the closure of its trading window effective October 1, 2026. This measure applies to all Designated Persons dealing in the company's securities.

The restriction is in place for the consideration of standalone un-audited financial results for the quarter and half year ended September 30, 2026 (Q2FY27). The company notified the BSE Limited on September 24, 2026, in compliance with regulatory guidelines.

Trading window reopening timeline

The trading window will reopen 48 hours after the announcement of the Q2FY27 financial results becomes generally available to the public. This protocol ensures that no insider information is traded upon prior to public disclosure.

The closure was intimated to the Department of Corporate Service at BSE Limited pursuant to the circular dated April 2, 2019. Bhawana Sharma, Company Secretary and Compliance Officer, signed the notice on behalf of the Jaipur-based hospital chain.

Historical Stock Returns for SHARMEH

1 Day5 Days1 Month6 Months1 Year5 Years
+0.35%-9.57%-9.54%-18.30%-47.84%+259.86%

How might the upcoming Q2FY27 financial results influence investor sentiment and stock volatility for Sharma East India Hospitals once the trading window reopens?

What are the projected growth trends for Sharma East India Hospitals' Jaipur-based operations compared to its broader regional expansion strategy?

How will the company's capital expenditure plans for medical infrastructure evolve following the release of these standalone financial results?

Sharma East India Hospitals files FY26 report, schedules AGM for September 30

scanx
Reviewed by
Suketu GScanX News Team
Key Highlights
  • Sharma East India Hospitals filed its FY26 annual report with total income of ₹3,608.91 lakh
  • Net profit after tax stood at ₹124.27 lakh, marginally down from ₹124.43 lakh in FY25
  • The 37th AGM is scheduled for September 30, 2026, via video conferencing
  • Radhika Sathe is up for re-appointment as a director retiring by rotation
  • No dividend was declared; profits will be reinvested into the business
powered bylight_fuzz_icon
50428523

*this image is generated using AI for illustrative purposes only.

Sharma East India Hospitals and Medical Research Ltd has filed its annual report for FY26 and scheduled its 37th Annual General Meeting (AGM) for September 30, 2026. The Board of Directors concluded its meeting on September 8, 2026, approving the financial statements and key administrative resolutions.

The AGM will be held via Video Conferencing or Other Audio-Visual Means (OAVM) at 3:00 pm. The primary agenda includes the adoption of the Audited Financial Statements for the financial year ended March 31, 2026, along with the reports of the Board of Directors and Auditors.

Financial Performance

The company reported a total income of ₹3,608.91 lakh for FY26, an increase from ₹3,018.59 lakh in FY25. Revenue from operations stood at ₹3,593.30 lakh, up from ₹2,987.20 lakh in the previous year.

Profit before tax rose to ₹156.42 lakh from ₹141.28 lakh in FY25. Net profit after tax was reported at ₹124.27 lakh, compared to ₹124.43 lakh in FY25. Earnings per share (basic and diluted) remained stable at ₹3.78 per share, down slightly from ₹3.79 per share in the prior year.

Metric FY26 FY25 Change
Total Income ₹3,608.91 lakh ₹3,018.59 lakh +19.5%
Revenue from Operations ₹3,593.30 lakh ₹2,987.20 lakh +20.3%
Profit Before Tax ₹156.42 lakh ₹141.28 lakh +10.7%
Net Profit After Tax ₹124.27 lakh ₹124.43 lakh -0.1%
EPS (Basic & Diluted) ₹3.78 ₹3.79 -0.3%

Key Approvals and Agenda

The board meeting resulted in several critical approvals:

  • Approval of the Director’s Report and related annexures for FY26.
  • Approval of the Annual Report for FY25-26 and the Notice of the 37th AGM.
  • Re-appointment of Radhika Sathe (DIN: 10645753) as a director, liable to retire by rotation.
  • Determination of a fee to be charged from members for delivery of documents in their desired mode, proposed at ₹50.00 per document.

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the company submitted the notice to BSE Limited. The notice is also available on the company’s website.

Shareholder Logistics

Shareholders must note the following dates for e-voting and record-keeping:

Event Date Time
Cut-off date for e-voting entitlement September 23, 2026 N/A
Register of Members closure start September 24, 2026 N/A
E-voting period start September 27, 2026 9:00 am
E-voting period end September 29, 2026 5:00 pm
AGM Date September 30, 2026 3:00 pm
Register of Members closure end September 30, 2026 N/A

The Register of Members and Share Transfer Books will remain closed from September 24, 2026, to September 30, 2026, inclusive. No dividend was recommended for the year under review, as the board considered it financially prudent to reinvest profits into the business.

Historical Stock Returns for SHARMEH

1 Day5 Days1 Month6 Months1 Year5 Years
+0.35%-9.57%-9.54%-18.30%-47.84%+259.86%

How does the company plan to allocate the retained earnings to drive future revenue growth beyond the current 20.3% operational increase?

What specific capital expenditure or expansion projects are prioritized in the upcoming fiscal year to justify the decision against declaring a dividend?

Given the divergence between rising top-line revenue and stagnant net profit, what cost-control measures or margin-improvement strategies are expected for FY27?

More News on SHARMEH

1 Year Returns:-47.84%